|
"徐志宏"的相關文件
顯示項目 1-50 / 154 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2022-01-27 |
多水源配水系統操作成本最佳化之研究
|
Hsu, Chih-Hung; 徐志宏 |
| 臺大學術典藏 |
2018-09-10T15:33:37Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, S.-H. and Kuo, T.-C. and Wu, H. and Guo, J.-C. and Hsu, C. and Hsu, C.-H. and Tien, Y.-W. and Yeh, K.-H. and Cheng, A.-L. and Kuo, S.-H.; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; 郭頌鑫;鄭安理;徐志宏;許駿;葉坤輝;郭哲銓;田郁文;郭庭均;楊士弘; Yang, Shih-Hung; TING-CHUN KUO; Yang, Shih-Hung; Yang, Shih-Hung; Kuo, Ting-Chun; Kuo, Ting-Chun; YU-WEN TIEN; Kuo, Ting-Chun; ANN-LII CHENG; Wu, Hsu; Guo, Jhe-Cyuan; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chiun; Hsu, Chih-Hung; Hsu, Chih-Hung; Tien, Yu-Wen; Tien, Yu-Wen; Tien, Yu-Wen; Yeh, Kun-Huei; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2018-09-10T15:20:29Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Yeh, C.-C. and Hsu, C.-H. and Shao, Y.-Y. and Ho, W.-C. and Tsai, M.-H. and Feng, W.-C. and Chow, L.-P.; Yeh, Chao-Chi;Hsu, Chih-Hung;Shao, Yu-Yun;Ho, Wen-Ching;Tsai, Mong-Hsun;Feng, Wen-Chi;Chow, Lu-Ping; 邵幼雲;周綠蘋;徐志宏; MONG-HSUN TSAI; Yeh, Chao-Chi; LU-PING CHOW; Hsu, Chih-Hung; Shao, Yu-Yun; Ho, Wen-Ching; Tsai, Mong-Hsun; Feng, Wen-Chi; Chow, Lu-Ping; 蔡孟勳 |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy
|
Hsu, Chih-Hung; Koong, Albert C.; Chang, Daniel T.; Cheng, Jason Chia-Hsien; Lu, Shao-Lun;Hsu, Feng-Ming;Tsai, Chiao-Ling;Wu, Jian-Kuan;Lee, Jang-Ming;Huang, Pei-Ming;Hsu, Chih-Hung;Koong, Albert C.;Chang, Daniel T.;Cheng, Jason Chia-Hsien; Lu, S.-L. and Hsu, F.-M. and Tsai, C.-L. and Wu, J.-K. and Lee, J.-M. and Huang, P.-M. and Hsu, C.-H. and Koong, A.C. and Chang, D.T. and Chia-Hsien Cheng, J.; 成佳憲;徐志宏;李章銘;黃培銘;蔡巧琳;許峰銘;吳簡坤; 成佳憲; JANG-MING LEE; Lu, Shao-Lun; PEI-MING HUANG; Hsu, Feng-Ming; Tsai, Chiao-Ling; Wu, Jian-Kuan; Lee, Jang-Ming; Huang, Pei-Ming |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu, Chih-Hung; Cheng, Ann-Lii; Yeh, Kun-Huei; Wang, Hsiu-Po; Cheng, Jason Chia-Hsien; Lee, Jang-Ming; Huang, Pei-Ming; Chang, Chin-Hao; Hsieh, Min-Shu; PEI-MING HUANG; Lin, Chia-Chi; ANN-LII CHENG; JANG-MING LEE; Guo, Jhe-Cyuan;Huang, Ta-Chen;Lin, Chia-Chi;Hsieh, Min-Shu;Chang, Chin-Hao;Huang, Pei-Ming;Lee, Jang-Ming;Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Wang, Hsiu-Po;Yeh, Kun-Huei;Cheng, Ann-Lii;Hsu, Chih-Hung; Guo, J.-C. and Huang, T.-C. and Lin, C.-C. and Hsieh, M.-S. and Chang, C.-H. and Huang, P.-M. and Lee, J.-M. and Hsu, F.-M. and Cheng, J.C.-H. and Wang, H.-P. and Yeh, K.-H. and Cheng, A.-L. and Hsu, C.-H.; 林家齊;鄭安理;成佳憲;黃大成;徐志宏;葉坤輝;謝明書;郭哲銓;李章銘;王秀伯;黃培銘;許峰銘;張晉豪; MIN-SHU HSIEH; Guo, Jhe-Cyuan; Huang, Ta-Chen; Hsu, Feng-Ming |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Hsieh, Min-Shu; Chang, Yih-Leong; Hsu, Feng-Ming; Wang, Chia-Chun;Cheng, Jason Chia-Hsien;Tsai, Chiao-Ling;Lee, Jang-Ming;Huang, Pei-Ming;Lin, Chia-Chi;Hsu, Chih-Hung;Hsieh, Min-Shu;Chang, Yih-Leong;Hsu, Feng-Ming; Wang, C.-C. and Cheng, J.C.-H. and Tsai, C.-L. and Lee, J.-M. and Huang, P.-M. and Lin, C.-C. and Hsu, C.-H. and Hsieh, M.-S. and Chang, Y.-L. and Hsu, F.-M.; 林家齊;張逸良;成佳憲;王嘉檇;徐志宏;謝明書;李章銘;黃培銘;蔡巧琳;許峰銘; 成佳憲; Wang, Chia-Chun; YIH-LEONG CHANG; JANG-MING LEE; Cheng, Jason Chia-Hsien; PEI-MING HUANG; Tsai, Chiao-Ling; Lee, Jang-Ming; Huang, Pei-Ming; Lin, Chia-Chi; Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T14:58:42Z |
Invasive Lobular Carcinoma of Breast Associated with Recurrent Metastases along Gastrointestinal Tract
|
郭弘揚;郭冠廷;徐志宏; KUAN-TING KUO |
| 臺大學術典藏 |
2018-09-10T14:53:05Z |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao, Y.-Y. and Ho, M.-C. and Cheng, A.-L. and Hsu, C.-H.; Shao, Yu-Yun;Ho, Ming-Chih;Cheng, Ann-Lii;Hsu, Chih-Hung; 邵幼雲;鄭安理;徐志宏;何明志; 邵幼雲;鄭安理;徐志宏;何明志; Shao, Yu-Yun; Shao, Yu-Yun; MING-CHIH HO; CHIH-HUNG HSU; Ho, Ming-Chih; Ho, Ming-Chih; Cheng, Ann-Lii; Yu-Yun Shao; Hsu, Chih-Hung; ANN-LII CHENG; Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T14:51:53Z |
beta-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
|
高祥豐;邵幼雲;鄭安理;徐志宏;呂理駿;謝明書;李宜軒; Lu, Li-Chun; MIN-SHU HSIEH; CHIH-HUNG HSU; Shao, Yu-Yun; Lee, Yi-Hsuan; HSIANG-FONG KAO; Yu-Yun Shao; Hsieh, Min-Shu; ANN-LII CHENG; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; Lu, Li-Chun;Shao, Yu-Yun;Lee, Yi-Hsuan;Hsieh, Min-Shu;Hsiao, Chi-Huang;Lin, Hsiao-Hui;Kao, Hsiang-Fong;Ma, Yu-Yi;Yen, Feng-Chu;Cheng, Ann-Lii;Hsu, Chih-Hung; Lu, Li-Chun and Shao, Yu-Yun and Lee, Yi-Hsuan and Hsieh, Min-Shu and Hsiao, Chi-Huang and Lin, Hsiao-Hui and Kao, Hsiang-Fong and Ma, Yu-Yi and Yen, Feng-Chu and Cheng, Ann-Lii and Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Shao, Yu-Yun; Liu, CJ; PEI-JER CHEN; Lai, MY; DING-SHINN CHEN; Lee, Yi-Hsuan; Hsieh, Min-Shu; JIA-HORNG KAO; Chen, PJ; Kao, JH; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Chen, DS.; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒; Hsu, CS; Hsu, C.-S.; Liu, C.-J.; Lai, M.-Y.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; Lu, Li-Chun; CHUN-JEN LIU |
| 東吳大學 |
2016 |
聯合國「擔保交易立法指南」之研究—兼論我國動產擔保制度的修法方向
|
徐志宏; SYU, JHIH-HONG |
| 國立臺灣大學 |
2016 |
Inhibition of the Wnt/beta-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
|
Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2016 |
The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy.
|
Kuo, Hung-Yang; Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Hsu, Chih-Hung; 林家齊; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯 |
| 國立臺灣大學 |
2016 |
M1a Nodal Involvement and Induction Taxane-Based Chemotherapy Before Neoadjuvant Chemoradiation Therapy Are Associated With Survival Outcomes in Pathological Complete Responder After Trimodality Treatment for Esophageal Squamous Cell Carcinoma
|
Lu, S. L.; Hsu, F. M.; Tsai, C. L.; Lee, J. M.; Huang, P. M.; Hsu, C. H.; Lin, C. C.; Chang, Y. L.; Hsieh, M. S.; Cheng, J. C. H.; 林家齊; 張逸良; 成佳憲; 徐志宏; 謝明書; 李章銘; 黃培銘; 蔡巧琳; 許峰銘 |
| 國立臺灣大學 |
2016 |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, Shih-Hung; Kuo, Ting-Chun; Wu, Hsu; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chih-Hung; Tien, Yu-Wen; Yeh, Kun-Huei; Cheng, Ann-Lii; Kuo, Sung-Hsin; 郭頌鑫; 鄭安理; 徐志宏; 許駿; 葉坤輝; 郭哲銓; 田郁文; 郭庭均; 楊士弘 |
| 國立臺灣大學 |
2016 |
Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy
|
Chen, Bang-Bin; Hsu, Chao-Yu; Yu, Chih-Wei; Liang, Po-Chin; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Shih, Tiffany Ting-Fang; 許昭禹; 鄭安理; 陳邦斌; 徐志宏; 許駿; 梁博欽; 游治維 |
| 國立臺灣大學 |
2016 |
Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma
|
Shao, Yu-Yun; Liu, Tsung-Hao; Lee, Ying-Hui; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2016 |
Tumor-associated neutrophils: an emerging player in the immune microenvironment of hepatocellular carcinoma
|
Lu, Li-Chun; Hsu, Chih-Hung; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2016 |
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
|
Lu, Li-Chun; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立臺灣大學 |
2016 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
|
Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿 |
| 國立臺灣大學 |
2016 |
Serum biomarkers of VEGF-A and TGF-beta 1 predict pathological response and survival of esophageal cancer patients treated with neoadjuvant chemoradiotherapy and esophagectomy
|
Cheng, Jason Chia-Hsien; Chiang, Yun; Hsu, Feng-Ming; Tsai, Chiao-Ling; Hsu, Chih-Hung; Lee, Jang-Ming; 成佳憲; 徐志宏; 李章銘; 蔡巧琳; 許?銘 |
| 國立臺灣大學 |
2015 |
Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer
|
Yeh, Chao-Chi; Hsu, Chih-Hung; Shao, Yu-Yun; Ho, Wen-Ching; Tsai, Mong-Hsun; Feng, Wen-Chi; Chow, Lu-Ping; 邵幼雲; 周綠蘋; 徐志宏 |
| 國立臺灣大學 |
2015 |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Wang, Chia-Chun; Cheng, Jason Chia-Hsien; Tsai, Chiao-Ling; Lee, Jang-Ming; Huang, Pei-Ming; Lin, Chia-Chi; Hsu, Chih-Hung; Hsieh, Min-Shu; Chang, Yih-Leong; Hsu, Feng-Ming; 林家齊; 張逸良; 成佳憲; 王嘉檇; 徐志宏; 謝明書; 李章銘; 黃培銘; 蔡巧琳; 許峰銘 |
| 國立臺灣大學 |
2015 |
Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC)
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 王秀伯; 張晉豪 |
| 國立臺灣大學 |
2015 |
Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
|
Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Huang, Pei-Ming; Lee, Jang-Ming; Hsu, Feng-Ming; Cheng, Jason Chia-Hsien; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯; 黃培銘; 許峰銘; 張晉豪 |
| 國立臺灣大學 |
2015 |
Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model
|
Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Chiang, Bor-Luen; Lee, Xiao-yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 張純榮; 鄭安理; 徐志宏; 江伯倫; 楊曜旭 |
| 國立臺灣大學 |
2015 |
Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials
|
Shao, Yu-Yun; Shau, Wen-Yi; Chan, Soa-Yu; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2015 |
Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
|
Shao, Yu-Yun; Hsu, Chih-Hung; Yeh, Kun-Huei; Chen, Ho-Min; Yeh, Yi-Chun; Lai, Chiu-Lin; Lin, Zhong-Zhe; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2015 |
Tumor c-Met expression and prognosis of advanced hepatocellular carcinoma patients treated with sorafenib
|
Shao, Yu Yun; Hsiao, Chi-Huang; Lee, Ray; Puig, Oscar; Chan, Soa-Yu; Li, Yong-Shi; Hsu, Chih-Hung; 徐志宏 |
| 國立臺灣大學 |
2015 |
High Serum Transforming Growth Factor-beta 1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
|
Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 黃昭源; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2015 |
Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer
|
Huang, Ta-Chen; Hsu, Chih-Hung; Lin, Chia-Chi; Tu, Yu-Kang; 林家齊; 杜裕康; 黃大成; 徐志宏 |
| 國立臺灣大學 |
2015 |
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
|
Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2015 |
Serum Transforming Growth Factor-beta 1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy
|
Lu, Shao-Lun; Hsu, Feng-Ming; Tsai, Chiao-Ling; Wu, Jian-Kuan; Lee, Jang-Ming; Huang, Pei-Ming; Hsu, Chih-Hung; Koong, Albert C.; Chang, Daniel T.; Cheng, Jason Chia-Hsien; 成佳憲; 徐志宏; 李章銘; 黃培銘; 蔡巧琳; 許峰銘; 吳簡坤 |
| 國立臺灣大學 |
2014 |
beta-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
|
Lu, Li-Chun; Shao, Yu-Yun; Lee, Yi-Hsuan; Hsieh, Min-Shu; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒 |
| 國立臺灣大學 |
2014 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H; 林家齊; 楊志新; 盧彥伸; 鄭安理; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2014 |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao, Yu-Yun; Ho, Ming-Chih; Cheng, Ann-Lii; Hsu, Chih-Hung; 邵幼雲; 鄭安理; 徐志宏; 何明志 |
| 國立臺灣大學 |
2014 |
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy
|
Shao, Yu-Yun; Wu, Chih-Horng; Lu, Li-Chun; Chan, Soa-Yu; Ma, Yu-Yi; Yen, Feng-Chu; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 吳志宏; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2014 |
Clinical Characteristics of Advanced Hepatocellular Carcinoma Patients with Prolonged Survival in the Era of Anti-angiogenic Targeted-therapy
|
Lu, Li-Chun; Shao, Yu-Yun; Chan, Soa-Yu; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2014 |
Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin
|
Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2014 |
High serum transforming growth factor beta 1 levels associated with poor survivals in patients with advanced hepatocellular carcinoma
|
Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Cheng, Ann-Lii; Hsu, Chih-Hung; 邵幼雲; 黃昭源; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2013 |
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma
|
Lu, Li-Chun; Shao, Yu-Yun; Kuo, Raymond N. C.; Lin, Zhong-Zhe; Yeh, Yi-Chun; Shau, Wen-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 郭年真; 呂理駿 |
| 國立臺灣大學 |
2013 |
Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
|
Hsu, Chih-Hung; Kang, Yoon Koo; Yang, Tsai-Shen; Shun, Chia-Tung; Shao, Yu-Yun; Su, Wu-Chou; Sandoval-Tan, Jennifer; Chiou, Tzeon-Jye; Jin, Kate; Hsu, Chiun; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 許駿; 孫家棟 |
| 國立臺灣大學 |
2013 |
Nuclear Expression of Glioma-Associated Oncogene Homo log 1 and Nuclear Factor-kappa B Is Associated with a Poor Prognosis of Pancreatic Cancer
|
Yang, Shih-Hung; Hsu, Chih-Hung; Lee, Jen-Chieh; Tien, Yu-Wen; Kuo, Sung-Hsin; Cheng, Ann-Lii; 郭頌鑫; 鄭安理; 李仁傑; 徐志宏; 田郁文; 楊士弘 |
| 國立臺灣大學 |
2013 |
Prognostic Factors of Metastatic or Recurrent Esophageal Squamous Cell Carcinoma in Patients Receiving Three-drug Combination Chemotherapy
|
Chen, Wei-Wu; Lin, Chia-Chi; Huang, Ta-Chen; Cheng, Ann-Lii; Yeh, Kun-Huei; Hsu, Chih-Hung; 林家齊; 陳偉武; 鄭安理; 黃大成; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2013 |
The Germline BIM Deletion Polymorphism Is Not Associated with the Treatment Efficacy of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Chang, Yung-Lin; Huang, Chung-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 黃昭源; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2013 |
Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Hsu, Chiun; Shao, Yu-Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2013 |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao, Yu-Yun; Liang, Po-Chin; Wu, Yao-Ming; Huang, Chun-Chieh; Huang, Kai-Wen; Cheng, Jason C.; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lin, Zhong-Zhe; 邵幼雲; 林宗哲; 鄭安理; 成佳憲; 黃凱文; 徐志宏; 許駿; 梁博欽; 吳耀銘 |
| 國立臺灣大學 |
2013 |
Survival of patients receiving radiofrequency ablation or ethanol injection for early-stage hepatocellular carcinoma.
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿; 郭年真 |
| 國立臺灣大學 |
2013 |
WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells.
|
Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2013 |
Unique histopathologic features of brain metastases from hepatocellular carcinoma
|
Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書 |
顯示項目 1-50 / 154 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
